Mga Batayang Estadistika
| CIK | 862668 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Escalon Medical Corp.
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
| May 14, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY PERIOD PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period ended March 31, 2025 Commission File Number 0-20127 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 33-0272839 (State or other jurisdiction of incorporation or org |
|
| April 4, 2025 |
Letter from Marcum LLP dated April 4, 2025 Exhibit 16 April 4, 2025 Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Commissioners: We have read the statements made by Escalon Medical Corp. under Item 4.01 of its Form 8-K dated April 2, 2025. We agree with the statements concerning our Firm in such Form 8-K; we are not in a position to agree or disagree with other statements of Escalon Medical Corp. contained ther |
|
| April 4, 2025 |
Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 2, 2025 Escalon Medical Corp. (Exact Name of Registrant as Specified in Charter) Pennsylvania 000-20127 33-0272839 (State or other jurisdiction of incorporation) (Commission Fil |
|
| February 14, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY PERIOD PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period ended December 31, 2024 Commission File Number 0-20127 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 33-0272839 (State or other jurisdiction of incorporation or |
|
| November 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY PERIOD PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period ended September 30, 2024 Commission File Number 0-20127 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 33-0272839 (State or other jurisdiction of incorporation or |
|
| September 30, 2024 |
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FORM 10-K For the Fiscal year ended June 30, 2024 Commission File Number 0-20127 Escalon Medical Corp. |
|
| May 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY PERIOD PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period ended March 31, 2024 Commission File Number 0-20127 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 33-0272839 (State or other jurisdiction of incorporation or org |
|
| February 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY PERIOD PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period ended December 31, 2023 Commission File Number 0-20127 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 33-0272839 (State or other jurisdiction of incorporation or |
|
| November 17, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY PERIOD PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period ended September 30, 2023 Commission File Number 0-20127 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 33-0272839 (State or other jurisdiction of incorporation or |
|
| November 15, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SEC FILE NUMBER 0-20127 FORM 12b-25 NOTIFICATION OF LATE FILING CUSIP NUMBER 296074305 ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For the Period Ended: September 30, 2023 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Re |
|
| October 13, 2023 |
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FORM 10-K For the Fiscal year ended June 30, 2023 Commission File Number 0-20127 Escalon Medical Corp. |
|
| September 29, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SEC FILE NUMBER 0-20127 FORM 12b-25 NOTIFICATION OF LATE FILING CUSIP NUMBER 296074305 ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For the Period Ended: June 30, 2023 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report |
|
| May 15, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY PERIOD PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period ended March 31, 2023 Commission File Number 0-20127 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 33-0272839 (State or other jurisdiction of incorporation or org |
|
| February 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY PERIOD PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period ended December 31, 2022 Commission File Number 0-20127 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 33-0272839 (State or other jurisdiction of incorporation or |
|
| November 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY PERIOD PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period ended September 30, 2022 Commission File Number 0-20127 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 33-0272839 (State or other jurisdiction of incorporation or |
|
| November 2, 2022 |
Letter from Friedman LLP, dated November 2, 2022. Exhibit 16.1 November 2, 2022 Securities and Exchange Commission 100 F Street, NE Washington, D.C. 20549 Commissioners: We have read the statements made by Escalon Medical Corp. under Item 4.01 of its Form 8-K dated November 2, 2022. We agree with the statements concerning our firm in such Form 8-K; we are not in a position to agree or disagree with other statements of Escalon Medical Corp. contai |
|
| November 2, 2022 |
Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 28, 2022 Escalon Medical Corp. (Exact Name of Registrant as Specified in Charter) Pennsylvania 000-20127 33-0272839 (State or other jurisdiction of incorporation) (Commission |
|
| September 28, 2022 |
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FORM 10-K For the Fiscal year ended June 30, 2022 Commission File Number 0-20127 Escalon Medical Corp. |
|
| May 13, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY PERIOD PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period ended March 31, 2022 Commission File Number 0-20127 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 33-0272839 (State or other jurisdiction of incorporation or org |
|
| February 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY PERIOD PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period ended December 31, 2021 Commission File Number 0-20127 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 33-0272839 (State or other jurisdiction of incorporation or |
|
| November 15, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY PERIOD PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period ended September 30, 2021 Commission File Number 0-20127 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 33-0272839 (State or other jurisdiction of incorporation or |
|
| October 22, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2021 Commission File Number 0-20127 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 33-0272839 (State or other jurisdiction of incorpora |
|
| September 27, 2021 |
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FORM 10-K For the Fiscal year ended June 30, 2021 Commission File Number 0-20127 Escalon Medical Corp. |
|
| May 14, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY PERIOD PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period ended March 31, 2021 Commission File Number 0-20127 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 33-0272839 (State or other jurisdiction of incorporation or org |
|
| February 16, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY PERIOD PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period ended December 31, 2020 Commission File Number 0-20127 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 33-0272839 (State or other jurisdiction of incorporation or |
|
| November 16, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY PERIOD PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period ended September 30, 2020 Commission File Number 0-20127 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 33-0272839 (State or other jurisdiction of incorporation or |
|
| October 26, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2020 Commission File Number 0-20127 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 33-0272839 (State or other jurisdiction of incorpora |
|
| September 28, 2020 |
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal year ended June 30, 2020 Commission File Number 0-20127 Escalon Medical Corp. |
|
| May 14, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY PERIOD PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period ended March 31, 2020 Commission File Number 0-20127 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 33-0272839 (State or other jurisdiction of incorporation or org |
|
| February 14, 2020 |
ESMC / Escalon Medical Corp. 10-Q - Quarterly Report - 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY PERIOD PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period ended December 31, 2019 Commission File Number 0-20127 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 33-0272839 (State or other jurisdiction of incorporation or |
|
| November 14, 2019 |
ESMC / Escalon Medical Corp. 10-Q - Quarterly Report - 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY PERIOD PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period ended September 30, 2019 Commission File Number 0-20127 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 33-0272839 (State or other jurisdiction of incorporation or |
|
| October 25, 2019 |
ESMC / Escalon Medical Corp. 10-K/A - Annual Report - 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2019 Commission File Number 0-20127 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 33-0272839 (State or other jurisdiction of incorpora |
|
| September 27, 2019 |
ESMC / Escalon Medical Corp. 10-K - Annual Report - 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal year ended June 30, 2019 Commission File Number 0-20127 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 33-0272839 (State or other jurisdiction of incorporation or organization |
|
| May 14, 2019 |
ESMC / Escalon Medical Corp. 10-Q Quarterly Report 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY PERIOD PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period ended March 31, 2019 Commission File Number 0-20127 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 33-0272839 (State or other jurisdiction of incorporation or org |
|
| February 14, 2019 |
ESMC / Escalon Medical Corp. 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY PERIOD PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period ended December 31, 2018 Commission File Number 0-20127 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 33-0272839 (State or other jurisdiction of incorporation or |
|
| November 14, 2018 |
ESMC / Escalon Medical Corp. 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY PERIOD PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period ended September 30, 2018 Commission File Number 0-20127 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 33-0272839 (State or other jurisdiction of incorporation or |
|
| October 26, 2018 |
ESMC / Escalon Medical Corp. 10-K/A (Annual Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2018 Commission File Number 0-20127 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 33-0272839 (State or other jurisdiction of incorpora |
|
| October 23, 2018 |
ESMC / Escalon Medical Corp. / Depiano Richard J - SC 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* Escalon Medical Corp. (Name of Issuer) Common Stock, par value $.01 per share (Title of Class of Securities) 296074305 (CUSIP Number) Richard J. DePiano, Jr. President and Chief Executive Officer 435 Devon Park Drive, Building 100 Wayne, PA 19087; telepho |
|
| October 22, 2018 |
ESMC / Escalon Medical Corp. / Escalon Medical Corp - SC 13D (Activist Investment) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* Escalon Medical Corp. (Name of Issuer) Common Stock, par value $.01 per share (Title of Class of Securities) 296074305 (CUSIP Number) Richard J. DePiano, Jr. President and Chief Executive Officer 435 Devon Park Drive, Building 100 Wayne, PA 19087; telepho |
|
| September 28, 2018 |
ESMC / Escalon Medical Corp. 10-K (Annual Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2018 Commission File Number 0-20127 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 33-0272839 (State or other jurisdiction of incorporation or organization |
|
| July 6, 2018 |
Business Loan Agreement dated June 29, 2018 between the Company and TD Bank, N.A. a101businessloanagreemen |
|
| July 6, 2018 |
Promissory Note dated June 29, 2018 between the Company and TD Bank, N.A. a102promissorynote |
|
| July 6, 2018 |
Assignment of Deposit Account dated June 29, 2018 between the Company and TD Bank, N.A. a103assignmentofdeposita |
|
| July 6, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): June 29, 2018 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 000-20127 330272839 (State or other jurisdiction (Commission (I.R.S. Employer o |
|
| May 14, 2018 |
ESMC / Escalon Medical Corp. 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY PERIOD PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period ended March 31, 2018 Commission File Number 0-20127 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 33-0272839 (State or other jurisdiction of incorporation or org |
|
| February 20, 2018 |
Escalon Medical Corp. (Form: 8-K) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): February 13, 2018 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 000-20127 330272839 (State or other juris |
|
| February 15, 2018 |
Statement with Respect to Shares filed February 14, 2018 EX-3.1 [graphic]PENNSYLVANIA DEPARTMENT OF STATE BUREAU OF CORPORATIONS AND CHARITABLE ORGANIZATIONS Return document by mail to: Statement with Respect to Shares Name Domestic Business Corporation DSCB:15-1522 (rev. 7/2015) Address *1522 * City State Zip Code Return document by email to: 1522 Read all instructions prior to completing. This form may be submitted online at https://www.corporations.p |
|
| February 15, 2018 |
Debt Exchange Agreement dated as of February 14, 2018 EX-10.1 |
|
| February 15, 2018 |
Escalon Medical Corp. (Form: 8-K) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): February 14, 2018 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 000-20127 330272839 (State or other juris |
|
| February 14, 2018 |
10.1 Source Code Licensing Agreement. SOURCE CODE LICENSE AGREEMENT This Source Code License Agreement (this “Agreement”) is entered into as of October 2, 2017 (the “Effective Date”) by and between Escalon Medical Corp. |
|
| February 14, 2018 |
ESMC / Escalon Medical Corp. 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY PERIOD PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period ended December 31, 2017 Commission File Number 0-20127 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 33-0272839 (State or other jurisdiction of incorporation or |
|
| February 13, 2018 |
ESMC / Escalon Medical Corp. / GRT CAPITAL PARTNERS L.L.C. Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. |
|
| January 24, 2018 |
Changes in Registrant's Certifying Accountant Escalon Medical Corp. (Form: 8-K) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): January 18, 2018 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 000-20127 330272839 (State or other jurisd |
|
| January 24, 2018 |
Letter Mayer Hoffman McCann P.C. dated 1 23 2018 EX-16.1 January 23, 2018 Securities and Exchange Commission 100 F Street N.E. Washington, D.C. 20549-7561 Dear Sirs/Mesdames: We have read Item 4.01 of Escalon Medical Corp?s Form 8-K dated January 18, 2018, and have the following comments: 1. We agree with the statements made in the first, second, third and fourth paragraphs of Item 4.01. 2. We have no basis on which to agree or disagree with the |
|
| November 14, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY PERIOD PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period ended September 30, 2017 Commission File Number 0-20127 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 33-0272839 (State or other jurisdiction of incorporation or |
|
| October 27, 2017 |
Escalon Medical 10-K/A (Annual Report) Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2017 Commission File Number 0-20127 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 33-0272839 (State or other jurisdiction of |
|
| September 28, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2017 Commission File Number 0-20127 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 33-0272839 (State or other jurisdiction of incorporation or organization |
|
| July 7, 2017 |
Escalon Medical Corp. (Form: 8-K) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): July 7, 2017 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 000-20127 330272839 (State or other jurisdicti |
|
| July 6, 2017 |
Escalon Medical LIVE FILING (Current Report/Significant Event) Escalon Medical Corp. (Form: 8-K) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): June 29, 2017 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 000-20127 330272839 (State or other jurisdict |
|
| May 18, 2017 |
Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule |
|
| May 18, 2017 |
Document SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
| May 18, 2017 |
Document ESCALON 2016 Annual Report May 18, 2017 Dear Shareholder: The board of directors and management cordially invite you to attend the annual meeting of the shareholders to be held on June 29, 2017 at 9:00 am at the corporate headquarters located at 435 Devon Park Drive, Building 100, Wayne, PA 19087. |
|
| May 15, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY PERIOD PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period ended March 31, 2017 Commission File Number 0-20127 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 33-0272839 (State or other jurisdiction of incorporation or org |
|
| February 14, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY PERIOD PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period ended December 31, 2016 Commission File Number 0-20127 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 33-0272839 (State or other jurisdiction of incorporation or |
|
| February 10, 2017 |
ESMC / Escalon Medical Corp. / GRT CAPITAL PARTNERS L.L.C. Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. |
|
| January 5, 2017 |
Escalon Medical Corp. (Form: 8-K) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): December 29, 2016 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 000-20127 330272839 (State or other juris |
|
| January 5, 2017 |
EX-10.1 INVENTORY ADVANCE AGREEMENT This AGREEMENT is entered into as of December 29, 2016 (the ?Effective Date?), between CDS Business Services, Inc. doing business as Newtek Business Credit (?Newtek?) maintaining a principal place of business at 1981 Marcus Avenue, Suite 130, Lake Success, NY 11042, and Escalon Medical Corp. (?Client?), a Pennsylvania corporation, maintaining a principal place o |
|
| November 30, 2016 |
ESMC / Escalon Medical Corp. / GRT CAPITAL PARTNERS L.L.C. Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. |
|
| November 18, 2016 |
Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY PERIOD PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period ended September 30, 2016 Commission File Number 0-20127 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 33-0272839 (State or other jurisdiction of incorpo |
|
| November 16, 2016 |
Escalon Medical LIVE FILING (Current Report/Significant Event) Escalon Medical Corp. (Form: 8-K) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): November 16, 2016 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 000-20127 330272839 (State or other juris |
|
| November 15, 2016 |
Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER: 0-20127 CUSIP NUMBER: 296074305 (Check One): ? Form 10-K ? Form 20-F ? Form 11-K x Form 10-Q ? Form N-SAR ? Form N-CSR For Period Ended: September 30, 2016 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Report on Form 10-Q ? Transition Report on Form N-SAR For the Transition Period Ended: Read Instruction (on back page) Before Preparing Form. |
|
| November 1, 2016 |
Escalon Medical 10-K/A (Annual Report) Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2016 Commission File Number 0-20127 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 33-0272839 (State or other jurisdiction of |
|
| October 12, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2016 Commission File Number 0-20127 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 33-0272839 (State or other jurisdiction of incorporation or organization |
|
| September 29, 2016 |
Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER: 0-20127 CUSIP NUMBER: 296074305 (Check One): x Form 10-K ? Form 20-F ? Form 11-K ? Form 10-Q ? Form N-SAR ? Form N-CSR For Period Ended: June 30, 2016 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Report on Form 10-Q ? Transition Report on Form N-SAR For the Transition Period Ended: Read Instruction (on back page) Before Preparing Form. |
|
| September 6, 2016 |
Escalon Medical LIVE FILING (Current Report/Significant Event) Escalon Medical Corp. (Form: 8-K) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): August 30, 2016 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 000-20127 330272839 (State or other jurisdi |
|
| August 19, 2016 |
Escalon Medical LIVE FILING (Current Report/Significant Event) Escalon Medical Corp. (Form: 8-K) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): August 18, 2016 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 000-20127 330272839 (State or other jurisdi |
|
| August 19, 2016 |
Escalon Medical LIVE FILING (Current Report/Significant Event) Escalon Medical Corp. (Form: 8-K) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): August 18, 2016 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 000-20127 330272839 (State or other jurisdi |
|
| May 16, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY PERIOD PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period ended March 31, 2016 Commission File Number 0-20127 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 33-0272839 (State or other jurisdiction of incorporation or org |
|
| March 7, 2016 |
Escalon Medical LIVE FILING (Current Report/Significant Event) Escalon Medical Corp. (Form: 8-K) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): March 2, 2016 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 000-20127 330272839 (State or other jurisdict |
|
| February 23, 2016 |
Escalon Medical Form 8-K (Current Report/Significant Event) Escalon Medical Corp. (Form: 8-K) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): February 19, 2016 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 000-20127 330272839 (State or other juris |
|
| February 16, 2016 |
ESMC / Escalon Medical Corp. / GRT CAPITAL PARTNERS L.L.C. Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. |
|
| February 16, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY PERIOD PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period ended December 31, 2015 Commission File Number 0-20127 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 33-0272839 (State or other jurisdiction of incorporation or |
|
| January 5, 2016 |
Escalon Medical LIVE FILING (Current Report/Significant Event) Escalon Medical Corp. (Form: 8-K) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): December 29, 2015 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 000-20127 330272839 (State or other juris |
|
| November 19, 2015 |
DEFA14A SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
| November 19, 2015 |
10-K ESCALON 2015 Annual Report November 11, 2015 Dear Shareholder: The board of directors and management cordially invite you to attend the annual meeting of the shareholders to be held on December 29, 2015 at 9:00 am at the corporate headquarters located at 435 Devon Park Drive, Building 100, Wayne, PA 19087. |
|
| November 19, 2015 |
DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule |
|
| November 16, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY PERIOD PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period ended September 30, 2015 Commission File Number 0-20127 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 33-0272839 (State or other jurisdiction of incorporation or |
|
| October 29, 2015 |
Escalon Medical LIVE FILING (Current Report/Significant Event) Escalon Medical Corp. (Form: 8-K) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): October 23, 2015 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 000-20127 330272839 (State or other jurisd |
|
| October 28, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2015 Commission File Number 0-20127 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 33-0272839 (State or other jurisdiction of incorpora |
|
| September 30, 2015 |
Escalon Medical LIVE FILING (Current Report/Significant Event) Escalon Medical Corp. (Form: 8-K) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): September 25, 2015 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 000-20127 330272839 (State or other juri |
|
| September 29, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2015 Commission File Number 0-20127 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 33-0272839 (State or other jurisdiction of incorporation or organization |
|
| September 28, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2015 Commission File Number 0-20127 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 33-0272839 (State or other jurisdiction of incorporation or organization |
|
| May 14, 2015 |
10-Q 1 esmc20150331-10q2015.htm 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY PERIOD PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period ended March 31, 2015 Commission File Number 0-20127 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 33-0272839 (State or other |
|
| February 13, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY PERIOD PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period ended December 31, 2014 Commission File Number 0-20127 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 33-0272839 (State or other jurisdiction of incorporation or |
|
| December 31, 2014 |
Submission of Matters to a Vote of Security Holders Escalon Medical Corp. (Form: 8-K) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): December 23, 2014 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 000-20127 330272839 (State or other juris |
|
| November 17, 2014 |
ESMC / Escalon Medical Corp. DEFA14A - - DEFA 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant þ Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e) |
|
| November 14, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY PERIOD PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period ended September 30, 2014 Commission File Number 0-20127 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 33-0272839 (State or other jurisdiction of incorporation or |
|
| November 13, 2014 |
ESMC / Escalon Medical Corp. DEFA14A - - DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant þ Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e) |
|
| November 13, 2014 |
ESMC / Escalon Medical Corp. DEF 14A - - DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant þ Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e) |
|
| November 13, 2014 |
ESMC / Escalon Medical Corp. ARS - - 10-K ESCALON 2014 Annual Report November 13, 2014 Dear Shareholder: The board of directors and management cordially invite you to attend the annual meeting of the shareholders to be held on December 23, 2014 at 9:00 am at the corporate headquarters located at 435 Devon Park Drive, Building 100, Wayne, PA 19087. |
|
| October 28, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2014 Commission File Number 0-20127 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 33-0272839 (State or other jurisdiction of incorpora |
|
| September 26, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2014 Commission File Number 0-20127 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 33-0272839 (State or other jurisdiction of incorporation or organization |
|
| May 14, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY PERIOD PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period ended March 31, 2014 Commission File Number 0-20127 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 33-0272839 (State or other jurisdiction of incorporation or org |
|
| February 14, 2014 |
ESMC2013.12.31-10Q 2014 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY PERIOD PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period ended December 31, 2013 Commission File Number 0-20127 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 33-0272839 (State or other jurisdict |
|
| January 3, 2014 |
Escalon Medical Corp. (Form: 8-K) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): December 28, 2013 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 000-20127 330272839 (State or other juris |
|
| November 14, 2013 |
ESCALON 2013 Annual Report November 15, 2013 Dear Shareholder: The board of directors and management cordially invite you to attend the annual meeting of the shareholders to be held on December 27, 2013 at 9:00 am at the corporate headquarters located at 100 Church Road, Suite 200, Ardmore, PA 19003. |
|
| November 14, 2013 |
ESCALON MEDICAL CORP. 2013 EQUITY INCENTIVE PLAN ESCALON MEDICAL CORP. 2013 EQUITY INCENTIVE PLAN The purpose of the Escalon Medical Corp. 2013 Equity Incentive Plan is to provide (i) designated employees of Escalon Medical Corp. (the “Company”) and its parents and subsidiaries, (ii) certain consultants and advisors who perform services for the Company or its parents or subsidiaries and (iii) non-employee members of the Board of Directors of the |
|
| November 14, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant þ Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e) |
|
| November 14, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant þ Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e) |
|
| November 12, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY PERIOD PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period ended September 30, 2013 Commission File Number 0-20127 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 33-0272839 (State or other jurisdiction of incorporation or |
|
| October 28, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2013 Commission File Number 0-20127 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 33-0272839 (State or other jurisdiction of incorpora |
|
| September 25, 2013 |
EX-99.01 ESCALON News Release Escalon® Medical Corp. Announces Executive Management Transition ARDMORE, Pa., September 25, 2013 — Escalon Medical Corp. (Nasdaq: ESMC) today announced that Richard J. DePiano, Chairman and Chief Executive Officer, will retire from day to day operations effective September 25, 2013. Mr. DePiano, age 72, will assume the role of executive Chairman of the Board of Direc |
|
| September 25, 2013 |
Escalon Medical Corp. (Form: 8-K) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): September 20, 2013 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 000-20127 330272839 (State or other juri |
|
| September 20, 2013 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2013 Commission File Number 0-20127 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 33-0272839 (State or other jurisdiction of incorporati |
|
| July 2, 2013 |
Submission of Matters to a Vote of Security Holders Escalon Medical Corp. (Form: 8-K) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): June 28, 2013 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 000-20127 330272839 (State or other jurisdict |
|
| May 22, 2013 |
Escalon Medical Corp. (Form: 8-K) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): May 17, 2013 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 000-20127 330272839 (State or other jurisdicti |
|
| May 17, 2013 | ||
| May 17, 2013 |
SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
| May 17, 2013 |
SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
| May 17, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2012 Commission File Number 0-20127 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 33-0272839 (State or other jurisdiction of incorpora |
|
| May 17, 2013 |
f ESCALON 2012 Annual Report 1 May 17,2013 Dear Shareholder: The board of directors and management cordially invite you to attend the annual meeting of the shareholders to be held on June 28, 20 13at 9:00 am at the corporate headquarters located at 435 Devon Park Drive, Building 100, Wayne, PA 19087. |
|
| May 15, 2013 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 9, 2013 ESCALON MEDICAL CORP. (Exact name of registrant as specified in its charter) Pennsylvania 0-20127 33-0272839 (State or other jurisdiction of incorporation) (Commis |
|
| May 10, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY PERIOD PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period ended March 31, 2013 Commission File Number 0-20127 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 33-0272839 (State or other jurisdiction of incorporation or org |
|
| February 14, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY PERIOD PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period ended December 31, 2012 Commission File Number 0-20127 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 33-0272839 (State or other jurisdiction of incorporation or |
|
| December 28, 2012 |
Escalon Medical Corp. (Form: 8-K) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): December 27, 2012 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 000-20127 330272839 (State or other juris |
|
| November 14, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY PERIOD PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period ended September 30, 2012 Commission File Number 0-20127 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 33-0272839 (State or other jurisdiction of incorporation or |
|
| October 26, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2012 Commission File Number 0-20127 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 33-0272839 (State or other jurisdiction of incorpora |
|
| October 18, 2012 |
Financial Statements and Exhibits, Other Events - LIVE FILING Escalon Medical Corp. (Form: 8-K) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): October 17, 2012 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 000-20127 330272839 (State or other jurisd |
|
| October 18, 2012 |
EX-99.1 ESCALON MEDICAL CORP. 435 Devon Park Drive Building 100 Wayne, PA 19087 (Nasdaq Capital Market: ESMC) AT THE COMPANY Richard J. DePiano Chairman and CEO 610/688-6830 FOR IMMEDIATE RELEASE ESCALON® MEDICAL CORP. PAYS IN FULL ITS REFINANCED DEBT Wayne, PA – October 18, 2012 – Escalon Medical Corp. (Nasdaq: ESMC) today announced the payment in full of its refinanced debt in connection with th |
|
| October 10, 2012 |
Escalon Medical Corp. (Form: 8-K) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): October 4, 2012 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 000-20127 330272839 (State or other jurisdi |
|
| October 10, 2012 |
EX-2.1 STOCK PURCHASE AGREEMENT by and among ESCALON MEDICAL CORP., DREW SCIENTIFIC, INC. and ERBA DIAGNOSTICS, INC. dated as of October 3, 2012 TABLE OF CONTENT STOCK PURCHASE AGREEMENT This Stock Purchase Agreement (this “Agreement”), dated as of October 3, 2012, is entered into by and among Escalon Medical Corp. (“Escalon”), a Pennsylvania corporation, Drew Scientific, Inc. a Texas corporation |
|
| October 10, 2012 |
EX-99.1 ESCALON MEDICAL CORP. 435 Devon Park Drive Building 100 Wayne, PA 19087 (Nasdaq Capital Market: ESMC) AT THE COMPANY Richard J. DePiano Chairman and CEO 610/688-6830 FOR IMMEDIATE RELEASE ESCALON® MEDICAL CORP. SELLS ITS CLINICAL DIAGNOSTICS BUSINESS Wayne, PA – October 4, 2012 – Escalon Medical Corp. (Nasdaq: ESMC) (the “Company”) today announced the sale of its Clinical Diagnostics Busin |
|
| September 26, 2012 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2012 Commission File Number 0-20127 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 33-0272839 (State or other jurisdiction of incorporati |
|
| August 17, 2012 |
Escalon Medical Corp. (Form: 8-K) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): August 13, 2012 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 000-20127 330272839 (State or other jurisdi |
|
| June 29, 2012 |
Escalon Medical Corp. (Form: 8-K) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): June 29, 2012 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 000-20127 330272839 (State or other jurisdict |
|
| May 17, 2012 |
Notice & Proxy Statement Table of Contents SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
| May 17, 2012 |
- NOTICE OF INTERNET AVAILABILITY Notice of Internet Availability SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
| May 15, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q Mark One x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED March 31, 2012 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 0-20127 Escalon Medical Corp. |
|
| February 22, 2012 |
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Escalon Medical Corp. (Form: 8-K) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): February 15, 2012 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 000-20127 330272839 (State or other juris |
|
| February 14, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q Mark One x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED DECEMBER 31, 2011 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 0-20127 Escalon Medical Corp. |
|
| January 23, 2012 |
EX-99.01 ESCALON MEDICAL CORP. 435 Devon Park Drive Building 100 Wayne, PA 19087 (Nasdaq Capital Market: ESMC) AT THE COMPANY Richard J. DePiano Chairman and CEO 610/688-6830 ESCALON SUBSIDIARY, DREW SCIENTIFIC, INC., ANNOUNCES THAT ITS SUBSIDARY BH HOLDINGS, S.A.S. HAS INITIATED THE FILING OF AN INSOLVENCY DECLARATION IN FRANCE Wayne, PA – January 20, 2012– Escalon Medical Corp.’s (Nasdaq Market: |
|
| January 23, 2012 |
Financial Statements and Exhibits, Material Impairments - LIVE FILING Escalon Medical Corp. (Form: 8-K) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): January 18, 2012 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 000-20127 330272839 (State or other jurisd |
|
| November 14, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q Mark One x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2011 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 0-20127 Escalon Medical Corp. |
|
| October 28, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2011 Commission File Number 0-20127 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 33-0272839 (State or other jurisdiction of incorpora |
|
| September 28, 2011 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2011 Commission File Number 0-20127 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 33-0272839 (State or other jurisdiction of incorporati |
|
| July 7, 2011 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): June 30, 2011 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 000-20127 330272839 (State or other jurisdiction (Commission (I.R.S. Employer o |
|
| May 20, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Defin |
|
| May 20, 2011 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14 |
|
| May 16, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q Mark One ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED March 31, 2011 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 0-20127 Escalon Medical Corp. |
|
| May 6, 2011 |
May 6, 2011 Via Edgar U. S. Securities and Exchange Commission Division of Corporate Finance Attention: Brian Cascio, Accounting Branch Chief 100 F Street, N.E., Mail Stop 3030 Washington, DC 20549 Re: Escalon Medical Corp. Form 10-K for the fiscal year ended June 30, 2010 Filed October 12, 2010 Form 10-Q for the quarterly period ended December, 2010 File No. 000-20127 Dear Mr. Cascio: This corres |
|
| May 6, 2011 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): April 29, 2011 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 000-20127 330272839 (State or other jurisdiction (Commission (I.R.S. Employer |
|
| May 6, 2011 |
29 April 2011 BIOCODE-HYCEL FRANCE S.A. and BH Holdings FIRST AMENDMENT TO THE AGREEMENT FOR THE SALE OF A BUSINESS AS A GOING CONCERN 1 FIRST AMENDMENT TO AGREEMENT FOR THE SALE OF A BUSINESS AS A GOING CONCERN BETWEEN THE UNDERSIGNED: 1. Immunodiagnostic Systems France, SAS (formerly Biocode-Hycel France S.A.), a company organized under the laws of France having its registered office at Le Bassi |
|
| May 6, 2011 |
ESCALON MEDICAL CORP. 435 Devon Park Drive Building 100 Wayne, PA 19087 (Nasdaq Capital Market: ESMC) AT THE COMPANY Richard J. DePiano Chairman and CEO 610/688-6830 ESCALON? ANNOUNCES THE REFINANCING OF ITS DEBT Wayne, PA ? May 5, 2011 ? Escalon Medical Corp. (Nasdaq Market: ESMC) announced the refinancing of its debt in connection with the acquisition of certain assets of Biocode Hycel (?Biocode |
|
| April 13, 2011 |
Escalon Medical Corp. 435 Devon Park Drive Building 100 Wayne, PA 19087-1698 Tel. 610-688-6830 Fax 610-688-3641 April 13, 2011 Via Edgar U. S. Securities and Exchange Commission Division of Corporate Finance Attention: Brian Cascio, Accounting Branch Chief 100 F Street, N.E., Mail Stop 3030 Washington, DC 20549 Re: Escalon Medical Corp. Form 10-K for the fiscal year ended June 30, 2010 Filed Octob |
|
| February 11, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q Mark One ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED DECEMBER 31, 2010 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 0-20127 Escalon Medical Corp. |
|
| November 15, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q Mark One ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2010 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 0-20127 Escalon Medical Corp. |
|
| October 28, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2010 Commission File Number 0-20127 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania (State or other jurisdiction of incorporation or org |
|
| October 12, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2010 Commission File Number 0-20127 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 33-0272839 (State or other jurisdiction of (I.R.S. Employer incorporatio |
|
| September 29, 2010 |
ESCALON MEDICAL CORP. 435 Devon Park Drive Building 100 Wayne, PA 19087 (Nasdaq Capital Market: ESMC) AT THE COMPANY Richard J. DePiano Chairman and CEO 610/688-6830 FOR IMMEDIATE RELEASE September 28, 2010 ESCALON? REPORTS FISCAL 2010 RESULTS Wayne, PA ? September 28, 2010 ? Escalon Medical Corp. (Nasdaq Capital Market: ESMC) today announced results for its fiscal year ended June 30, 2010. Consol |
|
| September 29, 2010 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): September 28, 2010 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 000-20127 330272839 (State or other jurisdiction (Commission (I.R.S. Emplo |
|
| September 29, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): ? Form 10-K o Form 20-F o Form 11-K o Form 10-Q o Form N-SAR o Form N-CSR For Period Ended: o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Transition Report on Form 10-Q o Transition Report on Form N-SAR For the Transitio |
|
| July 7, 2010 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): June 30, 2010 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 000-20127 330272839 (State or other jurisdiction (Commission (I.R.S. Employer o |
|
| June 16, 2010 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14 |
|
| May 20, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q Mark One ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED March 31, 2010 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 0-20127 Escalon Medical Corp. |
|
| May 18, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): o Form 10-K o Form 20-F o Form 11-K o Form 10-Q ? Form N-SAR o Form N-CSR For Period Ended: March 31, 2010 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Transition Report on Form 10-Q o Transition Report on Form N-SAR Fo |
|
| May 6, 2010 |
ASSET PURCHASE AGREEMENT by and between Vascular Solutions, Inc. and Escalon Vascular IP Holdings, Inc. April 30, 2010 TABLE OF CONTENTS 1 EXHIBIT LIST Exhibit A Exhibit B Exhibit C Exhibit D Assignment and Assumption Agreement Certificate of Officer of Seller Certificate of Officer of Buyer Assignment of Intellectual Property ASSET PURCHASE AGREEMENT This ASSET PURCHASE AGREEMENT (this ?Agreement |
|
| May 6, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): April 30, 2010 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 000-20127 330272839 (State or other jurisdiction (Commission (I.R.S. Employer |
|
| May 6, 2010 |
GUARANTEE This Guarantee (this ?Guarantee?) is delivered by Escalon Medical Corp., a Pennsylvania corporation (?Parent?) for the benefit of Vascular Solutions, Inc., a Minnesota corporation (?Vascular?) and its respective officers, directors, employees, agents and shareholders. WHEREAS, Vascular is entering into that certain Asset Purchase Agreement, dated as of the date hereof, with Escalon Vascu |
|
| May 6, 2010 |
ESCALON MEDICAL CORP. 435 Devon Park Drive Building 100 Wayne, PA 19087 (Nasdaq Capital Market: ESMC) AT THE COMPANY Richard J. DePiano Chairman and CEO 610/688-6830 FOR IMMEDIATE RELEASE ESCALON? MEDICAL CORP. DIVEST OF ITS VASCULAR ACCESS PRODUCT LINE Wayne, PA ? May 3, 2010 ? Escalon Medical Corp. (Nasdaq: ESMC) today announced the divesture of its SMARTNEEDLE and pd ACCESS Doppler guided needl |
|
| February 22, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q Mark One ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED DECEMBER 31, 2009 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 0-20127 Escalon Medical Corp. |
|
| February 17, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): o Form 10-K o Form 20-F o Form 11-K o Form 10-Q ? Form N-SAR o Form N-CSR For Period Ended: December 31, 2009 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Transition Report on Form 10-Q o Transition Report on Form N-SAR |
|
| February 17, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): o Form 10-K o Form 20-F o Form 11-K o Form 10-Q ? Form N-SAR o Form N-CSR For Period Ended: o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Transition Report on Form 10-Q o Transition Report on Form N-SAR For the Transitio |
|
| November 16, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q Mark One ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2009 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 0-20127 Escalon Medical Corp. |
|
| October 28, 2009 |
Exhibit 21.1 SUBSIDIARIES OF ESCALON MEDICAL CORP.* Jurisdiction Name of Incorporation Sonomed, Inc. New York, USA Escalon Vascular Access, Inc. Delaware, USA Escalon Medical Europe GmbH Germany Escalon Digital Vision, Inc. D/B/A Escalon Digital Solutions Delaware, USA Escalon Pharmaceutical, Inc. Delaware, USA Drew Scientific Co. Limited United Kingdom Drew Scientific, Inc. Texas, USA JAS Diagnos |
|
| October 28, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2009 Commission File Number 0-20127 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 33-0272839 (State or other jurisdiction of incorpora |
|
| October 13, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2009 Commission File Number 0-20127 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 33-0272839 (State or other jurisdiction of (I.R.S. Employer incorporatio |
|
| September 29, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): ? Form 10-K o Form 20-F o Form 11-K o Form 10-Q o Form N-SAR o Form N-CSR For Period Ended: o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Transition Report on Form 10-Q o Transition Report on Form N-SAR For the Transitio |
|
| June 12, 2009 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14 |
|
| May 20, 2009 |
Escalon Medical Corp. 565 East Swedesford Road, Suite 200 Wayne, PA 19087 Tel.610-688-6830 ? Fax. 610-688-3641 May 20, 2009 VIA EDGAR Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Re: Escalon Medical Corp. File No. 333-157174 Registration Statement on Form S-3 Ladies and Gentlemen: Escalon Medical Corp. (the ?Company?) hereby withdrawals it?s request dated May 19, 2009 |
|
| May 20, 2009 |
May 20, 2009 VIA EDGAR Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Re: Escalon Medical Corp. File No. 333-157174 Registration Statement on Form S-3 Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, Escalon Medical Corp. (the ?Company?) hereby requests that the effective date of the Company?s Registration Statement on Form S-3 (File No. 333- |
|
| May 19, 2009 |
May 19, 2009 VIA EDGAR Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Re: Escalon Medical Corp. File No. 333-157174 Registration Statement on Form S-3 Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, Escalon Medical Corp. (the ?Company?) hereby requests that the effective date of the Company?s Registration Statement on Form S-3 (File No. |
|
| May 19, 2009 |
As filed with the Securities and Exchange Commission on May 19, 2009 As filed with the Securities and Exchange Commission on May 19, 2009 Registration Statement No. |
|
| May 15, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q Mark One ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2009 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 0-20127 Escalon Medical Corp. |
|
| April 17, 2009 |
Escalon Medical Corp. 435 Devon Park Drive Building 100 Wayne, PA 19087-1698 Tel. 610-688-6830 Fax 610-688-3641 April 17, 2009 Via Edgar U. S. Securities and Exchange Commission Division of Corporate Finance Attention: Brian Cascio, Accounting Branch Chief 100 F Street, N.E., Mail Stop 3030 Washington, DC 20549 Re: Escalon Medical Corp. (?the Company?) Form 10-K for the year ended June 30, 2008 Fi |
|
| March 17, 2009 |
Escalon Medical Corp. 435 Devon Park Drive Building 100 Wayne, PA 19087-1698 Tel. 610-688-6830 Fax 610-688-3641 March 17, 2009 VIA EDGAR Russell Mancuso Branch Chief Securities and Exchange Commission Division of Corporate Finance Washington, DC 20549 Re: Escalon Medical Corp (the ?Company?) Registration Statement on Form S-3 File Number 333-157174 Dear Mr. Mancuso: This correspondence is in respo |
|
| March 17, 2009 |
Escalon Medical Corp. 435 Devon Park Drive Building 100 Wayne, PA 19087-1698 Tel. 610-688-6830 Fax 610-688-3641 March 17, 2009 Via Edgar U. S. Securities and Exchange Commission Division of Corporate Finance Attention: Brian Cascio, Accounting Branch Chief 100 F Street, N.E., Mail Stop 3030 Washington, DC 20549 Re: Escalon Medical Corp. (?the Company?) Form 10-Q for the Fiscal Quarter Ended Decemb |
|
| February 17, 2009 |
EXHIBIT 10.4 31 December 2008 31 December 2008 BIOCODE-HYCEL FRANCE S.A. and BH Holdings AGREEMENT FOR THE SALE OF A BUSINESS AS A GOING CONCERN 2 Translation for information. AGREEMENT FOR THE SALE OF A BUSINESS AS A GOING CONCERN BETWEEN THE UNDERSIGNED: 1. Biocode-Hycel France S.A., a company organized under the laws of France having its registered office at Le Bassin 21320 Pouilly en Auxois, r |
|
| February 17, 2009 |
REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (this ?Agreement?) is made and entered into as of November 20, 2008, by and among Escalon Medical Corp. |
|
| February 17, 2009 |
SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this ?Agreement?) is dated as of November 20, 2008, among Escalon Medical Corp. |
|
| February 17, 2009 |
COMMON STOCK PURCHASE WARRANT To Purchase ___ Shares of Common Stock of Escalon Medical Corp. NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?SECURITIES ACT?), AND, ACCORDINGLY, NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISA |
|
| February 17, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q Mark One ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED DECEMBER 31, 2008 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 0-20127 Escalon Medical Corp. |
|
| February 9, 2009 |
As filed with the Securities and Exchange Commission on February 6, 2009 As filed with the Securities and Exchange Commission on February 6, 2009 Registration Statement No. |
|
| January 30, 2009 |
Escalon Medical Corp. 435 Devon Park Drive Building 100 Wayne, PA 19087-1698 Tel. 610-688-6830 Fax 610-688-3641 January 30, 2009 Via Edgar U. S. Securities and Exchange Commission Division of Corporate Finance Attention: Brian Cascio, Accounting Branch Chief 100 F Street, N.E., Mail Stop 3030 Washington, DC 20549 Re: Escalon Medical Corp. (?the Company?) Form 10-K for the Year Ended June 30, 2008 |
|
| January 7, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): December 31, 2008 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 000-20127 330272839 (State or other jurisdiction (Commission (I.R.S. Employ |
|
| January 7, 2009 |
ESCALON MEDICAL CORP. 435 Devon Park Drive, Building 100 Wayne, PA 19087 (Nasdaq Capital Market: ESMC) AT THE COMPANY AT FINANCIAL RELATIONS BOARD Richard J. DePiano Chairman and CEO Joseph Calabrese 212/827-3772 610/688-6830 ESCALON? MEDICAL CORP. COMPLETES BOLT-ON ACQUISITION, ENHANCES MARKET POSITION IN FRANCE AND EXPANDS PRODUCT OFFERING ACQUIRES HEMATOLOGY BUSINESS ASSETS FROM BIOCODE HYCEL W |
|
| November 21, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): November 20, 2008 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 000-20127 330272839 (State or other jurisdiction (Commission (I.R.S. Employ |
|
| November 21, 2008 |
ESCALON MEDICAL CORP. 565 East Swedesford Road, Suite 200 Wayne, PA 19087 (Nasdaq Capital Market: ESMC) AT THE COMPANY AT FINANCIAL RELATIONS BOARD Richard J. DePiano Chairman and CEO Joseph Calabrese 212/827-3772 610/688-6830 ESCALON? MEDICAL CORP. COMPLETES $1.1 MILLION PRIVATE EQUITY FINANCING Wayne, PA ? November 21, 2008 ? Escalon Medical Corp. (Nasdaq Small Cap: ESMC) today announced that on |
|
| November 14, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q Mark One ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2008 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 0-20127 Escalon Medical Corp. |
|
| October 28, 2008 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2008 Commission File Number 0-20127 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 33-0272839 (State or other jurisdi |
|
| September 29, 2008 |
Exhibit 10.15 STOCK PURCHASE AGREEMENT AMONG DREW SCIENTIFIC, INC. JAS DIAGNOSTICS, INC AND THE STOCKHOLDERS OF JAS DIAGNOSTICS, INC. May 30, 2008 TABLE OF CONTENTS Page I Representations and Warranties of the Company and Shareholders 1 1.01 Organization and Qualification 2 1.02 Authorization 2 1.03 Capitalization 2 1.04 Financial Condition 2 1.05 Tax Liabilities 3 1.06 Legal Proceedings and Compl |
|
| September 29, 2008 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2008 Commission File Number 0-20127 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 33-0272839 (State or other jurisdiction of incorporati |
|
| June 5, 2008 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): May 30, 2008 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 000-20127 330272839 (State or other jurisdiction (Commission (I.R.S. Employer of |
|
| June 5, 2008 |
ESCALON MEDICAL CORP. 435 Devon Park Drive Building 100 Wayne, PA 19087 (Nasdaq Capital Market: ESMC) AT THE COMPANY AT FINANCIAL RELATIONS BOARD Richard J. DePiano Chairman and CEO Joseph Calabrese 212/827-3772 610/688-6830 ESCALON? ENHANCES POSITION WITHIN IVD REAGENT MARKET WITH STRATEGIC ACQUISITION OF JAS DIAGNOSTICS Wayne, PA ? June 5, 2008 ? Escalon Medical Corp. (Nasdaq Capital Market: ESM |
|
| May 15, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q Mark One ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2008 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 0-20127 Escalon Medical Corp. |
|
| February 14, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q Mark One ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED DECEMBER 31, 2007 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 0-20127 Escalon Medical Corp. |
|
| December 27, 2007 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): December 21, 2007 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 000-20127 330272839 (State or other jurisdiction (Commission (I.R.S. Employ |
|
| December 27, 2007 |
ESCALON MEDICAL CORP. 565 East Swedesford Road, Suite 200 Wayne, PA 19087 (Nasdaq Capital Market: ESMC) AT THE COMPANY AT FINANCIAL RELATIONS BOARD Richard J. DePiano Chairman and CEO Joseph Calabrese 212/827-3772 610/688-6830 ESCALON? ANNOUNCES EXECUTIVE PROMOTIONS Wayne, PA ? December 27, 2007 ? Escalon Medical Corp. (Nasdaq Capital Market: ESMC) today announced two executive management promotio |
|
| December 5, 2007 |
AMENDMENTS TO THE BYLAWS OF ESCALON MEDICAL CORP. EXHIBIT 3.2 AMENDMENTS TO THE BYLAWS OF ESCALON MEDICAL CORP. Article 26, Article 27 and Article 28 are amended and restated to read in their entirety as follows: ?ARTICLE 26 SHARES; SHARE CERTIFICATES SECTION 26.1 (a) Shares of any or all of the Corporation?s classes or series of capital stock, or any part thereof, may be evidenced by certificates for shares of stock, in such form as the Board of |
|
| December 5, 2007 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): November 30, 2007 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 000-20127 330272839 (State or other jurisdiction (Commission (I.R.S. Employ |
|
| December 5, 2007 |
PENNSYLVANIA DEPARTMENT OF STATE CORPORATION BUREAU Articles of Amendment ? Domestic Corporation Entity Number (15 Pa. |
|
| November 30, 2007 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14 |
|
| March 2, 2007 |
ESCALON MEDICAL CORP. 565 East Swedesford Road, Suite 200 Wayne, PA 19087 (Nasdaq Capital Market: ESMC) AT THE COMPANY AT FINANCIAL RELATIONS BOARD Richard J. DePiano Chairman and CEO Joseph Calabrese 212/827-3772 610/688-6830 ESCALON? TO RECEIVE $9.6 MILLION IN SETTLEMENT AGREEMENT WITH INTRALASE CORP. Wayne, PA ? February 28, 2007 ? Escalon Medical Corp. (Nasdaq Capital Market: ESMC) today annou |
|
| March 2, 2007 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): February 27, 2007 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 000-20127 330272839 (State or other jurisdiction (Commission (I.R.S. Employ |
|
| July 6, 2006 |
ESCALON MEDICAL CORP. 565 East Swedesford Road, Suite 200 Wayne, PA 19087 (Nasdaq Small Cap: ESMC) AT THE COMPANY AT FINANCIAL RELATIONS BOARD Richard J. DePiano Chairman and CEO Joseph Calabrese 212/827-3772 610/688-6830 FOR IMMEDIATE RELEASE ESCALON? ANNOUNCES THE APPOINTMENT OF ROBERT O?CONNOR AS CHIEF FINANCIAL OFFICER Wayne, PA ? July 6, 2006 ? Escalon Medical Corp. (Nasdaq Small Cap: ESMC) t |
|
| July 6, 2006 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): June 30, 2006 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 000-20127 330272839 (State or other jurisdiction (Commission (I.R.S. Employer o |
|
| June 22, 2006 |
Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): June 19, 2006 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 000-20127 330272839 (State or other jurisdiction (Commission (I.R.S. Employer o |
|
| June 22, 2006 |
Exhibit 16 June 21, 2006 Securities and Exchange Commission 100 F. Street N.E. Washington, D.C. 20549 We have been furnished with a copy of the response to item 4.01 of Form 8-K for the event that occurred on June 19, 2006, to be filed by our former client, Escalon Medical Corporation. We agree with the statements made in response to that item insofar as they relate to our firm. Very truly yours, |
|
| June 6, 2006 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): May 31, 2006 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 000-20127 330272839 (State or other jurisdiction (Commission (I.R.S. Employer of |
|
| February 28, 2006 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): February 27, 2006 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 000-20127 330272839 (State or other jurisdiction (Commission (I.R.S. Employ |
|
| September 29, 2005 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): September 29, 2005 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 000-20127 330272839 (State or other jurisdiction (Commission (I.R.S. Emplo |
|
| September 29, 2005 |
ESCALON MEDICAL CORP. 565 East Swedesford Road, Suite 200 Wayne, PA 19087 (Nasdaq Small Cap: ESMC) AT THE COMPANY AT FINANCIAL RELATIONS BOARD Richard J. DePiano Chairman and CEO Joseph Calabrese 212/827-3772 610/688-6830 FOR IMMEDIATE RELEASE ESCALON? REPORTS FOURTH QUARTER AND FISCAL 2005 RESULTS Wayne, PA ? September 29, 2005 ? Escalon Medical Corp. (Nasdaq Small Cap: ESMC) today announced resu |
|
| July 15, 2005 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): July 15, 2005 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 000-20127 330272839 (State or other jurisdiction (Commission (I.R.S. Employer o |
|
| July 15, 2005 |
ESCALON MEDICAL CORP. 565 East Swedesford Road, Suite 200 Wayne, PA 19087 (Nasdaq Small Cap: ESMC) AT THE COMPANY AT FINANCIAL RELATIONS BOARD Richard J. DePiano Chairman and CEO Joseph Calabrese 212/827-3772 610/688-6830 FOR IMMEDIATE RELEASE ESCALON MEDICAL CORP NAMES MARK H. KARSCH CHIEF FINANCIAL OFFICER Wayne, PA?July 15, 2005?Escalon Medical Corp. (NASDAQ: ESMC) today announced that Mark H. |
|
| June 29, 2005 |
SUPPLEMENTAL EXECUTIVE RETIREMENT BENEFIT AGREEMENT SUPPLEMENTAL EXECUTIVE RETIREMENT BENEFIT AGREEMENT THIS SUPPLEMENTAL EXECUTIVE BENEFIT AGREEMENT is made and entered into as of June 23, 2005 by and between Escalon Medical Corp. |
|
| June 29, 2005 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): June 23, 2005 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 000-20127 330272839 (State or other jurisdiction (Commission (I.R.S. Employer o |
|
| May 24, 2005 |
AT THE COMPANY AT FINANCIAL RELATIONS BOARD Richard J. DePiano Chairman and CEO Joseph Calabrese 212/827-3772 610/688-6830 FOR IMMEDIATE RELEASE ESCALON? ANNOUNCES COURT DECISIONS AND CURRENT STATUS IN INTRALASE LITIGATION Wayne, PA ? May 16, 2005 ? Escalon Medical Corp. (Nasdaq Small Cap: ESMC) today filed a complaint against IntraLase Corp. (Nasdaq: ILSE) in the Court of Chancery of the State of |
|
| May 24, 2005 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): May 18, 2005 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 000-20127 330272839 (State or other jurisdiction (Commission (I.R.S. Employer of |
|
| April 7, 2005 |
UNITED STATES DISTRICT COURT CENTRAL DISTRICT OF CALIFORNIA CIVIL MINUTES ? GENERAL Case No. |
|
| April 7, 2005 |
By: /s/ Richard J. DePiano, Sr. cc: James A. Lightman, Esquire William J. Link, Ph.D. Richard J. DePiano CEO & Chairman Direct Dial (610) 254-8904 E-Mail: [email protected] March 31, 2005 VIA FAX AND CERTIFIED MAIL, RETURN RECEIPT REQUESTED Mr. Robert J. Palmisano IntraLase Corporation 3 Morgan Irvine, CA 92618 Re: Amended and Restated License Agreement (?Agreement?) Dear Mr. Palmisano: On March 8, 2005, we received Jan Weir?s letter via Federal Express enclosing IntraLase Co |
|
| April 7, 2005 |
Termination of a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): April 1, 2005 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 000-20127 330272839 (State or other jurisdiction (Commission (I.R.S. Employer o |
|
| January 6, 2005 |
January 5, 2005 Securities and Exchange Commission 450 Fifth Street, N.W. Washington, D.C. 20549 Commissioners: We have read the statements made by Escalon Medical Corporation (copy attached), which we understand will be filed with the Securities and Exchange Commission, pursuant to Item 4.01 of Form 8-K, as part of the Company?s Form 8-K report dated December 30, 2004. We agree with the statement |
|
| January 6, 2005 |
Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): December 30, 2004 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 000-20127 330272839 (State or other jurisdiction (Commission (I.R.S. Employ |
|
| January 3, 2005 |
Memorandum To: From: Date: Re: Rich DePiano Jeff O’Donnell December 28, 2004 Escalon Medical Memorandum To: From: Date: Re: Rich DePiano Jeff O?Donnell December 28, 2004 Escalon Medical Dear Rich: It has been a pleasure to serve on Escalon?s Board for the past five years. |
|
| January 3, 2005 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): December 29, 2004 Escalon Medical Corp. (Exact name of registrant as specified in its charter) Pennsylvania 000-20127 330272839 (State or other jurisdiction (Commission (I.R.S. Employ |
|
| December 7, 2004 |
Entry into a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): December 1, 2004 Escalon Medical Corp (Exact name of registrant as specified in its charter) Pennsylvania 000-20127 330272839 (State or other jurisdiction (Commission (I.R.S. Employer |
